FDA warns Savannah Chrisley's weight loss website about misleading drug claims

tmz.com

The FDA has warned Savannah Chrisley's weight loss website for making false and misleading claims about prescription weight loss drugs. The federal agency's warning letter cited Chrisley's website for implying compounded semaglutide and tirzepatide products were FDA-approved, which they are not. Chrisley's website has since updated its wording to comply with federal regulations, stating "clinically studied results" and adding disclaimers.


With a significance score of 0.7, this news ranks in the top 96% of today's 29590 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


FDA warns Savannah Chrisley's weight loss website about misleading drug claims | News Minimalist